Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
High GHRH-R Selectivity No GHS-R1a Cross-Reactivity Modified GRF (1-29) demonstrates high selectivity for GHRHR, with minimal cross-reactivity to other pituitary hormone receptors including the growth hormone secretagogue receptor (GHS-R1a) that mediates the effects of ghrelin and GHRPs such as Ipamorelin
Researchers looking for GHK-Cu peptide for sale often prioritize manufacturing standards, reliable sourcing, and product consistency
NAD+ is made from precursors like niacin, and at Balanced Healthcare, it is available as part of IV therapy, as an injection, or as a nasal spray
What does the in-vitro literature actually report
US$ 22.76
US$ 28.34
US$ 28.41
US$ 27.89
